New cell drug company on all therapies-Ever Supreme Biotechnology Co., LTD.

Cell Therapy CMO：

Ever Supreme offers the cell products (ADCV、DC-CIK、CIK、GDT and BMSC) needed by medical institution under the Regulations Governing Specific Cellular Therapeutic Technology of 2018 promogulated by Taiwan FDA.

 

Cells Products as CMO：

(1).Advantages of Ever Supreme Bio Technology in Marketing:

 

 

 

(2).Joint Medical Facilities in Taiwan

 

 

 

 (3).RGSCTT Services

 

 

 

(4). Indications of Treatment by Ever Supreme under RGSCTT

(5). Clinical Data under RGSCTT (ADCV01)

 

 

 

■ Data shows that patients with reception of DC treatment survive longer.

 

1. 19 cases on reception of DC therapy with 6 or more vails show survival days for at least 260 days and above, the longest survival days had exceeded more than 418 days (and continues to be rise).
2. 31 cases on reception of DC therapy with greater than 6 vails have significantly shown a higher impact than without treatment, showed a survival day of 193±82.1 days, the p-value in between is 0.011, a data demonstrates longer survival time.

 

 

■ A Stage IV colorectal cancer patient who had received DC therapy, whose tumor marker are drastically decreased and maintain stable.

 

 

 

(6). Clinical Data under RGSCTT(DC-CIK)

■ A Stage IV Hepatoma patient who had received DC-CIK therapy, whose tumor marker are maintained stable range, no deterioration.

 

 

 

■ A Stage IV Hepatoma patient who had received DC-CIK therapy, whose tumor marker are maintained stable range, no deterioration.

 

 

 4.CPU sites

 

 

 

Look for

Product licensing, Joint-Venture, Strategic Alliance, Sales & Distribution

 

Booth No. M804